Concepedia

Mark C. Grier

MC

Statistics

Publications

12

Citations

646

H-Index

12

Active since

1993

Affiliations

Paratek Pharmaceuticals (United States)(Current)

Virginia Commonwealth University Medical Center

Rutgers, The State University of New Jersey

Mark C. Grier is an author at Paratek Pharmaceuticals (United States) specializing in pharmacology, drug discovery, and life sciences.

Publications per year

1993–2024

12

Publications

12

Catalytic asymmetric allylation reactions. 3. Extension to methallylstannane, comparison of procedures, and observation of a nonlinear effect

Gary E. Keck, Dhileepkumar Krishnamurthy, Mark C. Grier · The Journal of Organic Chemistry · 1993 · 168 citations

, , +10

A Structure/Activity Relationship Study on Arvanil, an Endocannabinoid and Vanilloid Hybrid

Vincenzo Di Marzo, Graeme Griffin, Luciano De Petrocellis et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 88 citations · Full text

, , +14

<i>N</i>-Hydroxybenzimidazole Inhibitors of the Transcription Factor LcrF in <i>Yersinia</i>: Novel Antivirulence Agents

Oak K. Kim, Lynne Garrity-Ryan, Victoria J. Bartlett et al. · Journal of Medicinal Chemistry · 2009 · 62 citations · Full text

, , +8

Novel anti-infection agents: Small-molecule inhibitors of bacterial transcription factors

Todd E. Bowser, Victoria J. Bartlett, Mark C. Grier et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 56 citations · Full text

, , +16

Novel Pyrazole Cannabinoids: Insights into CB1Receptor Recognition and Activation

Jenny L. Wiley, Renée G. Jefferson, Mark C. Grier et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 54 citations

, , +16

1–5 of 12